![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 28, 2024 5:33:29 PM
And there's so much going on. Today, for example, Baudax filed a CH11. Will this give us the opportunity to bid on Tera-Immune?
https://www.sec.gov/ixviewer/ix.html?doc=/Archives/edgar/data/1780097/000119312524049000/d800225d8k.htm
And Sanofi's notice of appointing 3 Independent Directors yesterday, having already announced plans to spin-off their healthcare business, suggests preparations to ready the spin-off for Nasdaq listing.
https://www.sec.gov/Archives/edgar/data/1121404/000119312524047460/d702412dex993.htm
And as Preciouslife1's article informed us today, "Novavax expects full-year 2024 revenue to come in between $800 million and $1 billion. That forecast reflects an expected $500 million to $600 million in revenue from advanced purchase agreements and $300 million to $400 million from commercial market product sales, royalties and other revenue from the company’s “partner-related activity.”
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173936647
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM